Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
Aesar, Affymetrix, Alfa, Brazil, constrained, Daniel, desired, Durbin, Eleventh, emulsion, expedient, impermissibly, Johnson, Korea, Matthey, member, noncurrent, Norway, Oregon, partner, Patrick, Plc, prospectively, repaid, satisfaction, Shine, South, Williamson
Removed:
AA, AB, absorption, acquiring, added, advertising, aggregating, American, Andrew, announcement, apportionment, approved, auction, bioscience, bioterrorism, book, CB, Cin, Cinven, combined, commencement, conditional, consulting, cushion, Deed, depreciated, device, distributed, DKC, Dr, earning, eclampsia, electrochemical, Emiko, enhanced, equaled, equipped, escrowed, exchanged, excluding, exercisable, exert, exit, expended, Family, fee, finalization, forfeiture, formal, formed, Geographical, Governance, ICP, Igenza, imposition, input, Lambda, laminar, Lancaster, land, lapsed, LLC, Luxembourg, mailed, mailing, managed, Manager, Michael, miniature, modest, perpetual, person, pursue, qPCR, rata, representative, resale, schedule, sensing, separately, Sorensen, statute, surviving, tender, Terasaki, terminal, Thomson, transition, ultraviolet, Unaudited, undelivered, vendor, ventilation, venture, VSOE, WACC, Weston
Filing tables
Filing exhibits
Related press release
TMO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-187080) and Form S-8 (No. 33-51189, 33-54347, 333-127246, 333-138577, 333-146068, 333-148334, 333-152344, 333-161939 and 333-188846) of Thermo Fisher Scientific Inc. of our report dated February 25, 2016 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 25, 2016